Masanobu Yamada Selected Research

Thyrotropin-Releasing Hormone Receptors (Thyrotropin Releasing Hormone Receptor)

7/2002	A novel TRH-PFTAIRE protein kinase 1 pathway in the cerebellum: subtractive hybridization analysis of TRH-deficient mice.
2/2002	[Congenital central hypothyroidism due to the mutations of the thyrotropin-releasing hormone receptor gene].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanobu Yamada Research Topics

Disease

38	Neoplasms (Cancer) 01/2021 - 03/2002
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2002
13	Insulin Resistance 01/2022 - 12/2004
13	Adenoma (Adenomas) 11/2021 - 06/2007
11	Type 2 Diabetes Mellitus (MODY) 03/2022 - 09/2016
9	Hyperaldosteronism (Conn Syndrome) 10/2022 - 08/2011
9	Hypothyroidism 01/2022 - 02/2002
9	Lung Neoplasms (Lung Cancer) 06/2020 - 08/2010
8	Body Weight (Weight, Body) 03/2020 - 10/2006
7	Hypertension (High Blood Pressure) 01/2021 - 12/2003
6	Graves Disease (Basedow Disease) 01/2022 - 12/2006
6	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2015
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2020 - 04/2014
6	Inflammation (Inflammations) 11/2019 - 01/2014
6	Pituitary Neoplasms (Pituitary Adenoma) 01/2017 - 04/2002
5	Obesity 01/2022 - 04/2014
5	Diabetes Mellitus 04/2021 - 12/2015
5	Cushing Syndrome 01/2019 - 01/2011
4	Hyperthyroidism 01/2022 - 01/2015
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2020 - 07/2017
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 09/2015
4	Chronic Hepatitis C 02/2018 - 12/2015
3	Chronic Renal Insufficiency 10/2022 - 03/2019
3	Glucose Intolerance 01/2022 - 08/2011
3	Heart Failure 04/2021 - 01/2014
3	Disease Progression 07/2020 - 09/2014
3	Gastroesophageal Reflux (GERD) 01/2020 - 01/2014
3	Non-alcoholic Fatty Liver Disease 01/2020 - 03/2016
3	Pheochromocytoma 12/2019 - 04/2012
3	Hypokalemia 01/2019 - 12/2006
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 01/2014
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 05/2018 - 01/2012
3	Pneumonia (Pneumonitis) 01/2018 - 01/2015
3	Infections 11/2017 - 06/2014
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 03/2016
3	Neoplasm Metastasis (Metastasis) 12/2015 - 01/2010
3	Prolactinoma (Prolactinomas) 01/2011 - 06/2007
2	Thyroiditis 05/2021 - 01/2015
2	Anemia 04/2021 - 10/2017
2	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 05/2018
2	Fatty Liver 07/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

18	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
15	AldosteroneIBA 11/2021 - 08/2011
11	Messenger RNA (mRNA)IBA 06/2020 - 04/2002
10	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2019 - 01/2011
8	Insulin (Novolin)FDA Link 03/2022 - 03/2016
8	Pharmaceutical PreparationsIBA 01/2020 - 01/2014
7	Thyroid HormonesIBA 01/2022 - 01/2006
6	CytokinesIBA 11/2019 - 01/2013
6	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2019 - 06/2007
6	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 03/2013 - 01/2006
5	amrubicinIBA 07/2020 - 04/2016
4	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2019
4	ipragliflozinIBA 07/2020 - 12/2014
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
4	LeptinIBA 01/2020 - 10/2006
4	AlbuminsIBA 01/2019 - 09/2015
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2014
4	AntibodiesIBA 04/2017 - 04/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2017 - 09/2014
4	Liver X ReceptorsIBA 03/2013 - 01/2006
3	C-PeptideIBA 03/2022 - 03/2016
3	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2021 - 08/2010
3	ReninIBA 01/2021 - 08/2011
3	SodiumIBA 10/2020 - 12/2014
3	Cisplatin (Platino)FDA LinkGeneric 03/2020 - 03/2014
3	Sodium-Glucose Transport ProteinsIBA 01/2020 - 09/2016
3	dapagliflozinIBA 01/2020 - 01/2015
3	Leptin ReceptorsIBA 01/2020 - 10/2006
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2020 - 08/2017
3	trioctyl phosphine oxide (TOPO)IBA 01/2020 - 08/2017
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 08/2013
3	CatecholaminesIBA 12/2019 - 06/2015
3	Alanine Transaminase (SGPT)IBA 12/2018 - 10/2015
3	GlucocorticoidsIBA 05/2018 - 01/2014
3	Fetal Proteins (Fetoprotein)IBA 02/2018 - 09/2015
3	Thyroglobulin FDA Link 01/2018 - 11/2013
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2017 - 08/2010
3	Tyrosine Kinase InhibitorsIBA 01/2017 - 01/2015
2	17,18-dihydroxyeicosapentaenoic acidIBA 01/2022 - 11/2019
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 01/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022 - 04/2009
2	CholesterolIBA 01/2022 - 01/2006
2	CreatinineIBA 01/2022 - 06/2017
2	Tyrosine (L-Tyrosine)FDA Link 12/2021 - 01/2020
2	SteroidsIBA 11/2021 - 01/2015
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 10/2021 - 11/2012
2	Angiotensin Receptor AntagonistsIBA 04/2021 - 12/2014
2	Hemoglobins (Hemoglobin)IBA 04/2021 - 03/2016
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2021 - 09/2016
2	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2020 - 08/2019
2	LipidsIBA 07/2020 - 09/2014
2	Sirtuin 1IBA 07/2020 - 04/2014
2	PotassiumIBA 01/2020 - 03/2019

Therapy/Procedure

26	Therapeutics 03/2022 - 12/2008
14	Drug Therapy (Chemotherapy) 07/2020 - 09/2014
4	Adrenalectomy 10/2022 - 06/2015
3	Glycemic Control 04/2021 - 07/2017
3	Chemoradiotherapy 12/2015 - 01/2015
2	Aftercare (After-Treatment) 10/2022 - 01/2021